Carcinoembryonic antigen-related cell adhesion molecule 5 (355-367)

Carcinoembryonic antigen-related cell adhesion molecule 5

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-251

Synonyms/Alias:Carcinoembryonic antigen-related cell adhesion molecule 5 (355-367)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
LWWVNNQSLPVSP
Areas of Interest
Antigen-presenting Cells; Cancer Research
Source#
Homo sapiens (human)
Epitope
355-367
Restricting HLA
HLA-DR11/DR13/DR14
References
Campi; Cancer Res 2003

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Modification ServicescGMP Peptide ServicePeptide CDMOPeptide Analysis ServicesCustom Conjugation ServiceEpitope Mapping ServicesPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x